Challenges in increasing access to buprenorphine treatment for opiate addiction.
The aims of this study are to assess psychiatrists' comfort using office-based opiate agonist treatment (OBOT) and to identify psychiatrist characteristics associated with OBOT comfort. A random sample of 2,323 AMA Masterfile of Physicians psychiatrists were surveyed through the 2002 APIRE National Survey of Psychiatric Practice (NSSP). Of the 52% responding (N = 1,203), 80.6% (SE = 1.8%) were not comfortable providing OBOT. Males, addiction-certified psychiatrists, and those treating substance abuse patients were more comfortable providing OBOT. These findings highlight significant barriers in providing buprenorphine treatment. Increasing the understanding of specific financing and services delivery barriers that clinicians face is needed to inform the development of effective integrated services models and policies to facilitate OBOT implementation.
West
Joyce C
JC
Psychiatric Research Network, American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209, USA. jwest@psych.org
Kosten
Thomas R
TR
Wilk
Joshua
J
Svikis
Dace
D
Triffleman
Elise
E
Rae
Donald S
DS
Narrow
William E
WE
Duffy
Farifteh F
FF
Regier
Darrel A
DA
D001291:Attitude of Health Personnel; D002047:Buprenorphine / Q000627:therapeutic use*; D003625:Data Collection; D003695:Delivery of Health Care / Q000639:trends; D004059:Diffusion of Innovation; D005260:Female; D005544:Forecasting; D007722:Health Knowledge, Attitudes, Practice; D006297:Health Services Accessibility / Q000639:trends*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000627:therapeutic use*; D009819:Office Visits; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D010824:Physicians' Offices; D011570:Psychiatry; D012494:Sampling Studies; D014481:United States
D009294:Narcotics; D002047:Buprenorphine